N/A N=35,953 Cancer Prevention Clinical Decision Support
Cancer Prevention
Primary: Composite Cancer Screening Tests up to Date — 3087; 2590; 3866 Participants — p=.025
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=615 Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet
Unspecified Adult Solid Tumor, Protocol Specific
Primary: Change in Fruit, Vegetable Consumption as Measured by Food Frequency Questionnaire at 3 Months — 2.7272727; 2.9758065; 2.7330645; 0.4720000 number of servings per day
N/A N=120 Healthy Eating for Colon Cancer Prevention
Colon Cancer
Primary: Adherence to Dietary Goals — 89; 85 percentage of participants meeting goals
Phase 2 N=42 Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women
DCIS
Primary: Number of Participants With a Change in Ki-67 Level — 15; 5; 3 Participants — p=0.004
N/A N=290 Utilizing Technology to Promote Cancer Prevention
Health Knowledge, Attitudes, Practice
Primary: Percentage of Participants to Learn New Information — 38.6 percentage of participants
N/A N=297 WIC-Based Intervention to Promote Healthy Eating Among Low-Income Mothers
Cancer Prevention · Diet Modification · Vegetable Intake
Primary: Vegetable Intake Carotenoid Scores at 3 Months — 227.11; 269.98 units on a scale — p=0.001
N/A N=135 Patient-Centered Cancer Prevention In Chinese Americans
H. Pylori Infection
Primary: Number of Participants With Eradication of H. Pylori (ITT) — 49; 54 Participants
N/A N=1,635 Breast Cancer Risk Reduction: A Patient Doctor Intervention
Breast Cancer
Primary: Knowledge of Breast Cancer Risk Factors — 48.9; 56.4 units on a scale
Phase 3 N=619 S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
Precancerous/Nonmalignant Condition · Prostate Cancer
Primary: Presence of Carcinoma of the Prostate as Measured by Biopsy — 48; 49 participants — p=0.73
N/A N=62 Optimizing an mHealth Intervention to Change Food Purchasing Behaviors for Cancer Prevention
Cancer
Primary: 1a. Dietary Intake: ASA24 (Fiber) — 18.45; 18.17; 15.89; 20.73 grams/day — p=.255
N/A N=508 Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
Cancer, Breast · Cancer, Colon · Cancer, Cervix
Primary: Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers — 85; 85; 85; 85 Participants
Phase 2 N=23 Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
Healthy, no Evidence of Disease · Tobacco Use Disorder
Primary: Baseline in Prostaglandin E2 (PGE2) Within Aberrant Crypt Foci (ACF) — 1.1; 3.4 µg/g protein
N/A N=35 Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer
Healthy Subject
Primary: Feasibility and Retention for a Trial With Daily Doses of 35 g of Fiber and 6.2 g of EPA +DHA (and Corresponding Comparators) — 14; 15; 1; 1 Participants
Phase 1 N=328 Vitamin D for Chemoprevention
Gastrointestinal Cancers · Prostate Cancer · Hypertension
Primary: Levels of Plasma 25(OH)D at Baseline, 3 Months and 6 Months. — 15.1; 16.2; 13.9; 15.7 ng/mL
N/A N=138 Previvors Recharge: A Resilience Program for Cancer Previvors
Hereditary Cancer · Mental Health Issue
Primary: Connor Davidson Resilience Scale (CDRISC) — 22.59; 23.53 score on a scale — p=.029
N/A N=266 Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Breast Cancer
Primary: Change in Absolute Breast Density — 65.53; 64.39; 65.08; 56.35 cm squared
Phase 2 N=1,075 Green Tea and Reduction of Breast Cancer Risk
Breast Cancer
Primary: Mammographic Density — 22.71; 21.84; 22.09; 21.13 Percent
Phase 2 N=126 Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
Breast Cancer
Primary: Change in Breast Epithelial Cell Proliferation as Measured by Ki-67 Labeling — .325; .289; -.418; -.461 Ki-67 labeling index
Phase 2 N=25 Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
Breast Cancer
Primary: Change in the Percentage of Breast Epithelial Cells Expressing Ki-67, From Baseline to 6 Months — -3.0 percentage of positive cells — p=<0.001
Phase 2 N=132 Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Lip and Oral Cavity Cancer · Oral Leukoplakia · Oropharyngeal Cancer
Primary: Relative Percent Change in Total Lesion Area After 6 Months on Study — -20.6; -17.1 percentage change
Phase 2 N=107 Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers
Lung Cancer · Tobacco Use Disorder
Primary: Urinary Levels of Biomarkers of NNK Metabolism — 42.8; 0.36; 0.28; 49.7 pmol/mg creatinine
N/A N=41,193 Strategies and Opportunities to Stop Colon Cancer in Priority Populations
Colorectal Cancer
Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05
Phase 2 N=87 Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer
Adenomatous Polyp · Colorectal Carcinoma
Primary: Difference (After Treatment Minus Before Treatment) of EGFR Expression — 0.17; -0.40; 0.21 ng/ml
N/A N=98 Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
Prostate Cancer Prevention
Primary: Change of Total Urine SFN (Sulforaphane) Metabolites — 4.75; -0.02 micromolar (µM) concentrations of urina
Phase 2 N=79 Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
Colon Cancer · Precancerous Condition · Rectal Cancer
Primary: Change of a Spectral Biomarker for Colonic Carcinogenesis (Called Spectral Slope or SPEC) From Baseline to 3 Months. — 40.72; 37.54; 43.45; 37.52 micron^-1 — p=0.11
N/A N=100 Screen to Save: A Colorectal Cancer Educational Intervention
Colorectal Cancer
Primary: Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — 1 score on a scale — p=0.0001
N/A N=36 Cancer Dietary Objectives Study
Cancer · Heart Disease
Primary: Dietary Quality — 38.78; 41.18; 39.76 score — p=0.14
N/A N=40 Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding
Smoking, Cigarette · Breastfeeding
Primary: Number of Participants With Smoking Abstinence — 8; 3 Participants
N/A N=40 Weight Loss Intervention for the Reduction of Cancer Risk and Health Disparities in Rural Ohio
Obesity-Related Malignant Neoplasm
Primary: Feasibility of a 15-week Telephone-based Weight Loss Intervention — 22; 11 Participants
N/A N=1,111 Helping Patients and Providers Make Better Decisions About Colorectal Cancer Screening
Cancer Screening Tests
Primary: Number of Participants Who Completed Colorectal Cancer Screening — 110; 95; 113; 113 Participants